Electroacupuncture + dexmedetomidine
Electroacupuncture + dexmedetomidine has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Aug 14, 2026: “Effect of Electroacupuncture Combined with Dexmedetomidine on Postoperative Cognitive Dysfunction in Hip and Knee Arthroplasty Patients”.
1 paper studies it2 findingsUpdated
See all 1 papers on electroacupuncture + dexmedetomidine
At a glance
The findings reach people, from one lab or study. 1 lab.
“The incidence of POCD was significantly lower in the EA+Dex group (10%) compared with the EA group (30%) and the Dex group (32.5%) (p < 0.05).”
None of its findings points the other way.
- 1 lab
- Human trial1
Studies in people
1 study gave electroacupuncture + dexmedetomidine to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases postoperative cognitive dysfunction10% vs 30% (EA group) and 32.5% (Dex group) down: Decreases serum S-100β, TNF-α and IL-6 | Randomized trial1 month | 120 peopleelderlyOlder adults; at 1 month after hip or knee arthroplasty | Complementary medicine research, Aug 14, 2026 |
What did studies of electroacupuncture + dexmedetomidine find?
2Studies of electroacupuncture + dexmedetomidine measured 2 outcomes: serum S-100β, TNF-α and IL-6 and postoperative cognitive dysfunction.
Serum S-100β, TNF-α and IL-6
downin humans1
1 study
Serum S-100β, TNF-α and IL-6
downin humans1
Electroacupuncture + dexmedetomidine decreases serum S-100β, TNF-α and IL-6 in humans (combination group compared with monotherapy groups).
“postoperative serum levels of S-100β, TNF-α, and IL-6 were significantly reduced in the combination group compared with the monotherapy groups (p < 0.05).”
Human trialcombination group compared with monotherapy groups
Complementary medicine research
Postoperative cognitive dysfunction
downin humans1
1 study
Postoperative cognitive dysfunction
downin humans1
Electroacupuncture + dexmedetomidine decreases postoperative cognitive dysfunction in humans (at 1 month after hip or knee arthroplasty) (10% vs 30% (EA group) and 32.5% (Dex group)).
“The incidence of POCD was significantly lower in the EA+Dex group (10%) compared with the EA group (30%) and the Dex group (32.5%) (p < 0.05).”
Human trialat 1 month after hip or knee arthroplasty1 month
Complementary medicine research